This paper is only available as a PDF. To read, Please Download here.
Abstract
Intravenous fluorescein dye given at the time of operation has been shown to be a
simple, safe, efficient, and inexpensive method of predicting the location and extent
of skin sloughs after radical cancer operations and amputations. Suggestions have
been made for the possible prevention of this troublesome complication.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The fluorescein test in the management of tubed (pedicle) flaps.Bull. Johns Hopkins Hosp. 1943; 73: 129
- New methods for determining viability of bowel.Arch. Surg. 1942; 45: 785
- Vascular prerequisites for successful skin grafting.Surgery. 1944; 15: 85
- The use of fluorescent dyes as tracers in biology and medicine.J. Electrochem. Soc. 1949; 95: 131C
- The use of fluorescein to determine the adequacy of the circulation.M. Clin. North America. 1942; 26: 943
- The technique of the fluorescein test to determine the adequacy of circulation in peripheral vascular diseases, the circulation time and capillary permeability.Bull. New York M. College, Flower and Fifth Ave. Hosp. 1943; 6: 78
- Alterations in capillary permeability in meningeal irritations.Am. J. M. Sc. 1946; 211: 611
- Fluorescein as an adjunct in surgery of the extrahepatic biliary passages.J. A. M. A. 1948; 138: 1039
- Fluorescein string test for localization of upper gastrointestinal hemorrhage.Surgery. 1958; 44: 644
Article info
Publication history
Received:
March 3,
1961
Identification
Copyright
© 1962 Published by Elsevier Inc.